D. E. Shaw & Co., Inc. Fibrogen Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.89 - $2.36 $79,912 - $211,902	-89,789 Reduced 89.81%	10,186 $9,000
Q1 2024 May 15, 2024	SELL	$0.73 - $2.73 $1.3 Million - $4.84 Million	-1,774,213 Reduced 94.67%	99,975 $234,000
Q4 2023 Feb 14, 2024	BUY	$0.38 - $0.91 $436,903 - $1.05 Million	1,149,746 Added 158.71%	1,874,188 $1.67 Million
Q3 2023 Nov 14, 2023	BUY	$0.79 - $2.83 $545,583 - $1.95 Million	690,612 Added 2041.42%	724,442 $623,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $59,087 - $488,600	23,730 Added 234.95%	33,830 $91,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $161,095 - $254,318	10,100 New	10,100 $188,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $144,324 - $184,836	12,660 New	12,660 $165,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $695,243 - $1.82 Million	-68,295 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $1.27 Million - $2.44 Million	68,295 New	68,295 $1.82 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $963,041 - $1.27 Million	-25,965 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $1.71 Million - $1.92 Million	-42,265 Reduced 61.94%	25,965 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $2.22 Million - $2.92 Million	68,230 New	68,230 $2.77 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $381,071 - $751,675	-16,355 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $187,423 - $260,485	-5,420 Reduced 24.89%	16,355 $701,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $239,778 - $314,149	6,484 Added 42.4%	21,775 $805,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $537,172 - $849,109	15,291 New	15,291 $691,000
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $7.01 Million - $9.81 Million	-163,677 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $5.98 Million - $9.47 Million	157,384 Added 2500.94%	163,677 $7.58 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $354,295 - $423,204	6,293 New	6,293 $382,000
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $1 Million - $1.43 Million	-23,861 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $796,957 - $1.29 Million	23,861	23,861 $1.28 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account